MANIYA NOVA SERRA: Open Payments
NPI 1093286718 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,184 in 148 payments from 20 companies in 2025. Trend: 2023 $3,092 · 2024 $3,124 · 2025 $3,184
Food & beverage: $3,184
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $569 |
| ABBVIE INC. | 28 | $484 |
| PFIZER INC. | 24 | $398 |
| Eisai Inc. | 8 | $221 |
| Otsuka America Pharmaceutical, Inc. | 10 | $215 |
| JAZZ PHARMACEUTICALS INC. | 4 | $197 |
| Aucta Pharmaceuticals, Inc. | 15 | $185 |
| SK Life Science, Inc. | 6 | $158 |
| Neurelis, Inc. | 7 | $149 |
| Teva Pharmaceuticals USA, Inc. | 2 | $130 |
Products named: Fintepla, NURTEC ODT, Leqembi, QULIPTA, REXULTI, EPIDIOLEX, Motpoly XR, ZAVZPRET.
Industry payments across FL — which companies pay providers there.
